Skip to content

Clinical trials

Phase 1 Carcinoma, Renal Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1 Country / region: Netherlands Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20081
20091
20101
20141
20152
20162
20171
20181
20191
20201
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Exelixis2
Radboud University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
CRISPR Therapeutics AG1
European Organisation for Research and Treatment of Cancer - EORTC1
Genentech, Inc.1
GlaxoSmithKline1
Incyte Corporation1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell16
Colorectal Neoplasms6
Neoplasms5
Head and Neck Neoplasms4
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Kidney Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Hepatocellular2
Carcinoma, Transitional Cell2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.